← back to search

Michael R. Jacobs

Case Western Reserve University · US
Area of research
Epidemiology · Molecular Medicine
Research interest
Research interests include Biology, Medicine, Microbiology, Klebsiella pneumoniae, Enterobacteriaceae, and Streptococcus pneumoniae.
h-index
citations
1,744
works
19
NIH funding
primary concept
email

Recent publications

Patients with COPD prioritise chronic symptoms and functional impact as key outcomes in exacerbation trials
2025cited by 0position: middledoi
A randomised-controlled Phase I de-escalation trial of Molnupiravir and Nirmatrelvir/Ritonavir combination for mild-moderate SARS-CoV-2 infection
medRxiv 2025cited by 0position: middledoi
Optimal dose and safety of intravenous favipiravir in hospitalised patients with SARS-CoV-2 infection: a Phase Ib, open-label, dose-escalating, randomised controlled study
medRxiv 2025cited by 0position: middledoi
A molecular analysis of meropenem–vaborbactam non-susceptible KPC-producing <i>Klebsiella pneumoniae</i>
Antimicrobial Agents and Chemotherapy 2024cited by 7position: middledoi
Pilot study evaluation of the eQUANT™ system for accelerated antimicrobial susceptibility testing of gram-negative organisms directly from positive blood cultures
Diagnostic Microbiology and Infectious Disease 2024cited by 2position: lastdoi
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing
PLoS ONE 2022cited by 22position: middledoi
Targeting Multidrug-Resistant <i>Acinetobacter</i> spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
mBio 2019cited by 117position: middledoi
Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission
The Lancet Infectious Diseases 2019cited by 64position: middledoi
Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort
Journal of Psychosomatic Research 2019cited by 34position: middledoi
Association of Laboratory Methods, Colonization Density, and Age With Detection of Streptococcus pneumoniae in the Nasopharynx
American Journal of Epidemiology 2019cited by 26position: middledoi
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234
Journal of Medicinal Chemistry 2018cited by 148position: middledoi
Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
Antimicrobial Agents and Chemotherapy 2017cited by 286position: middledoi
Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States
Antimicrobial Agents and Chemotherapy 2017cited by 246position: middledoi
Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial
PLoS ONE 2016cited by 116position: middledoi
Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II
Clinical Infectious Diseases 2015cited by 61position: middledoi
Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 <i>Klebsiella pneumoniae</i>
Proceedings of the National Academy of Sciences 2014cited by 337position: middledoi
Extensively Drug-Resistant Pseudomonas aeruginosa Isolates Containing <i>bla</i> <sub>VIM-2</sub> and Elements of Salmonella Genomic Island 2: a New Genetic Resistance Determinant in Northeast Ohio
Antimicrobial Agents and Chemotherapy 2014cited by 43position: middledoi
Pneumococcal Capsular Switching: A Historical Perspective
The Journal of Infectious Diseases 2012cited by 181position: middledoi
The multidrug-resistant PMEN1 pneumococcus is a paradigm for genetic success
Genome biology 2012cited by 54position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Robert A. Bonomo · Louis Stokes Cleveland VA Medical Center9 papers (2014–2024)Barry N. Kreiswirth · Center for Discovery7 papers (2014–2024)Liang Chen · South China Agricultural University5 papers (2014–2024)Federico Pérez · Case Western Reserve University5 papers (2014–2024)Andrea M. Hujer · Louis Stokes Cleveland VA Medical Center5 papers (2014–2024)Kristine M. Hujer · Case Western Reserve University4 papers (2015–2024)Laura J. Rojas · Case Western Reserve University3 papers (2017–2024)Keith P. Klugman · Emory University3 papers (2012–2019)Kalyan D. Chavda · Nanostring Technologies (United States)3 papers (2014–2015)Krisztina M. Papp‐Wallace · Case Western Reserve University3 papers (2017–2019)Philip N. Rather · Emory University3 papers (2014–2019)Henry F. Chambers · CNR de la Résistance aux Antibiotiques3 papers (2015–2024)Vance G. Fowler · Duke University3 papers (2015–2024)Steven H. Marshall · Louis Stokes Cleveland VA Medical Center3 papers (2014–2024)Alejandro J. Vila · University of Houston3 papers (2014–2022)Stephen D. Bentley · Wellcome Sanger Institute2 papers (2012–2012)Julian Parkhill · University of Cambridge2 papers (2012–2012)Barun Mathema · Boston University2 papers (2014–2017)Christopher R. Bethel · Case Western Reserve University2 papers (2018–2019)Caryn E. Good · Case Western Reserve University2 papers (2019–2024)